In this study, we aimed to deliver an encapsulated nucleic acid drug to the tumor site via delivery of VNP to ultimately achieve the goal of targeting the CCDC25 gene and thus inhibiting tumor metastasis. Here, CCDC25 is linked to neoplasm.